In accordance with the WHO, about 6% of individuals worldwide who get COVID-19, roughly 400 million folks, later develop a long-lasting type of the sickness. That reveals the situation stays a major public well being problem.
In 2021, through the COVID-19 pandemic, the College of Louvain (UCLouvain, Belgium) and its hospital, the Cliniques universitaires Saint-Luc, launched a large-scale examine to see whether or not long-term signs could possibly be predicted through the acute part of an infection. The objective was to higher perceive the organic mechanisms concerned and probably establish a preventive therapy.
A Bacterium Linked to Restoration
After 5 years of analysis, scientists recognized an vital position for Dolosigranulum pigrum, a bacterium that naturally lives within the respiratory microbiome. Larger ranges of this bacterium have been related to a decrease chance that lengthy Covid signs would persist.
Jean Cyr Yombi, Leïla Belkir, and Julien De Greef, UCLouvain professors and infectious illness specialists on the Cliniques universitaires Saint-Luc, examined the severity of lengthy Covid signs in 156 sufferers. They centered primarily on extreme fatigue, cognitive issues, and respiratory points (shortness of breath).
Laure Elens and Patrice Cani, additionally UCLouvain professors, together with Bradley Ward, a postdoctoral researcher on the UCLouvain Louvain Drug Analysis Institute, then analyzed blood samples and nasopharyngeal swabs for molecular signatures linked to this extra extreme type of the illness. These signatures could assist clarify why signs persist in some sufferers however not in others.
Clues From the Respiratory Microbiome
UCLouvain and Cliniques universitaires Saint-Luc researchers said, “This examine means that sure so-called protecting micro organism within the respiratory microbiome could also be related to improved restoration following viral respiratory infections (corresponding to lengthy Covid or influenza), and that their alteration (notably within the context of extreme an infection or non-targeted antibiotic remedy) could affect longer-term scientific outcomes.”
In easier phrases, when this bacterium is current in greater quantities, it seems to assist shield in opposition to lengthy Covid or extreme influenza (by a mechanism that has but to be elucidated). When it’s current at low ranges, researchers discovered a larger tendency towards creating a persistent type of the illness.
Implications for Future Remedies
Researchers already knew this bacterium had a protecting impact in infectious influenza. The brand new findings, revealed in Microbiology Spectrum, add to the proof that Dolosigranulum pigrum could also be useful.
Scientists hope the invention will pace up analysis and assist new therapy methods, together with the potential improvement of a probiotic, for instance, within the type of a nasal spray, that could possibly be used earlier than winter to assist shield folks from extreme infectious ailments corresponding to Covid-19 or influenza.
The examine additionally discovered that non-targeted antibiotics can have an effect on the respiratory microbiome’s capacity to defend in opposition to extreme infections. That’s another excuse cautious antibiotic use stays vital.
Reference: “Affiliation of nasopharyngeal Dolosigranulum pigrum and Corynebacterium species with post-acute sequelae of SARS-CoV-2 in a longitudinal cohort” by Bradley Ward, Laure B. Bindels, Jean-Luc Balligand, Bertrand Bearzatto, Guido Bommer, Patrice D. Cani, Julien De Greef, Joseph P. Dewulf, Laurent Gatto, Vincent Haufroid, Sébastien Jodogne, Benoît Kabamba, Sébastien Pyr dit Ruys, Didier Vertommen, Jean Cyr Yombi, Leïla Belkhir and Laure Elens, 17 March 2026, Microbiology Spectrum.
DOI: 10.1128/spectrum.02313-25
This analysis concerned the College of Louvain HYGIEIA consortium and the Cliniques universitaires Saint-Luc, and was made potential due to the assist of the Sofina Covid Solidarity Fund and partnerships with the Fondation Saint-Luc, the FNRS (by way of an emergency analysis grant) and the WEL Analysis Institute of the Walloon Area.
